Search

Author/Creator Kauff, Frank

1. Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial. Issue 1 (January 2016)

Authors:
Rummel, Mathias; Kaiser, Ulrich; Balser, Christina; Stauch, Martina; Brugger, Wolfram; Welslau, Manfred; Niederle, Norbert; Losem, Christoph; Boeck, Hans-Peter; Weidmann, Eckhart; von Gruenhagen, Ulrich; Mueller, Lothar; Sandherr, Michael; Hahn, Lars; Vereshchagina, Julia; Kauff, Frank; Blau, Wol...
Journal:
Lancet oncology
Issue:
Volume 17:Issue 1(2016:Feb.)
Page Start:
57
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Partial suppression of Oxa1 mutants by mitochondria‐targeted signal recognition particle provides insights into the evolution of the cotranslational insertion systems. (2nd January 2013)

Authors:
Funes, Soledad; Westerburg, Heike; Jaimes‐Miranda, Fabiola; Woellhaf, Michael W.; Aguilar‐Lopez, Jose L.; Janßen, Linda; Bonnefoy, Nathalie; Kauff, Frank; Herrmann, Johannes M.
Journal:
FEBS journal
Issue:
Volume 280:Number 3(2013)
Page Start:
904
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search